Literature DB >> 24052594

Risk factors for symptomatic and asymptomatic chikungunya infection.

Phatchani Nakkhara1, Virasakdi Chongsuvivatwong, Suwich Thammapalo.   

Abstract

BACKGROUND: In 2008, a chikungunya epidemic occurred in Southern Thailand. In many epidemics, there is a sizable number of asymptomatic cases. It is uncertain whether symptomatic and asymptomatic cases share the same risk factors.
METHODS: Residents aged 18 years or more from three villages were sampled, their venous blood tested for anti-chikungunya virus IgG (haemagglutination-inhibition [HI] technique), and a face-to-face interview conducted during a home visit.
RESULTS: Of 507 subjects selected, 314 (61.9%) were seropositive (HI titre≥1:10), of whom 148 (47.1%) were asymptomatic. Among subjects who reported fever and joint pain during the epidemic, 166 (97.1%) still had a positive titre. Having a garbage pile nearby and spending at least eight hours per day outdoors were associated with an increased risk of both symptomatic and asymptomatic chikungunya infection. Protective factors for symptomatic infection were age more than 58 and having a high level of formal education.
CONCLUSIONS: Transmission was determined by environmental conditions whereas symptoms were associated with personal biological factors and social setting.

Entities:  

Keywords:  Asymptomatic; Chikungunya; Risk factor; Symptomatic

Mesh:

Substances:

Year:  2013        PMID: 24052594     DOI: 10.1093/trstmh/trt083

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  30 in total

Review 1.  Zika Virus Emergence and Expansion: Lessons Learned from Dengue and Chikungunya May Not Provide All the Answers.

Authors:  Rebecca C Christofferson
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

2.  Reply to Gérardin et al.

Authors:  Fausto Bustos Carrillo; Aubree Gordon; Eva Harris
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

3.  Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection.

Authors:  Fausto Bustos Carrillo; Damaris Collado; Nery Sanchez; Sergio Ojeda; Brenda Lopez Mercado; Raquel Burger-Calderon; Lionel Gresh; Aubree Gordon; Angel Balmaseda; Guillermina Kuan; Eva Harris
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 4.  Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus.

Authors:  Muktha S Natrajan; Alejandra Rojas; Jesse J Waggoner
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

5.  Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas.

Authors:  Leila C Sahni; Rebecca S B Fischer; Rodion Gorchakov; Rebecca M Berry; Daniel C Payne; Kristy O Murray; Julie A Boom
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

6.  Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.

Authors:  Morgan J Hennessey; Esther M Ellis; Mark J Delorey; Amanda J Panella; Olga I Kosoy; Hannah L Kirking; Grace D Appiah; Jin Qin; Alison J Basile; Leora R Feldstein; Brad J Biggerstaff; Robert S Lanciotti; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

7.  Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand.

Authors:  Narong Nitatpattana; Kobkan Kanjanopas; Sutee Yoksan; Wichai Satimai; Narong Vongba; Sasiporn Langdatsuwan; Khajornpong Nakgoi; Supot Ratchakum; Nadia Wauquier; Marc Souris; Prasert Auewarakul; Jean-Paul Gonzalez
Journal:  Virol J       Date:  2014-10-21       Impact factor: 4.099

8.  Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients.

Authors:  Yiu-Wing Kam; Kwoon-Yong Pok; Kai Er Eng; Li-Kiang Tan; Simrandeep Kaur; Wendy W L Lee; Yee-Sin Leo; Lee-Ching Ng; Lisa F P Ng
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

9.  Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.

Authors:  Guillermina Kuan; Stephania Ramirez; Lionel Gresh; Sergio Ojeda; Marlon Melendez; Nery Sanchez; Damaris Collado; Nadezna Garcia; Juan Carlos Mercado; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2016-06-20

10.  Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months After the 2013 Emergence.

Authors:  Noellie Gay; Dominique Rousset; Patricia Huc; Séverine Matheus; Martine Ledrans; Jacques Rosine; Sylvie Cassadou; Harold Noël
Journal:  Am J Trop Med Hyg       Date:  2015-12-07       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.